Streetbeat News

TNON

Tenon Medical, Inc.

https://www.tenonmed.com

Industry

Medical - Devices

Tenon Medical, Inc., a medical device company, develops surgical implant systems to optimize sacroiliac joint fixation/fusion surgery and corresponding outcomes. It sells The CATAMARAN SIJ Fusion System that includes instruments and implants designed to prepare and fixate the SI-Joint for fusion in the United States and Puerto Rico. The company was founded in 2012 and is based in Los Gatos, California.

Open

2.69

Mkt cap

8.5M

Volume

145K

High

2.77

P/E Ratio

-0.10

52-wk high

20.00

Low

2.61

Div yield

N/A

52-wk low

2.61

Steven Van Dick has informed Tenon Medical of his decision to retire and resign from his positions, including as CFO.

Portfolio Pulse from Benzinga Newsdesk

May 22, 2024 | 8:49 pm

The article highlights significant pre-market movements in health care stocks on Monday. GT Biopharma, China Pharma Holdings, Kintara Therapeutics, PTC Therapeutics, China SXT Pharmaceuticals, and Cue Health saw notable gains, while Virios Therapeutics, Jaguar Health, Aesthetic Medical Intl, Akanda, Syra Health, and Tenon Medical experienced declines.

Portfolio Pulse from Benzinga Insights

May 20, 2024 | 12:06 pm

Tenon Medical shares are trading lower following the announcement of worse-than-expected Q1 sales results.

Portfolio Pulse from Benzinga Newsdesk

May 14, 2024 | 9:11 pm

Tenon Medical (NASDAQ:TNON) reported Q1 2024 earnings with a GAAP EPS of $(1.25), surpassing the $(1.34) estimate, and sales of $719.00K, missing the $783.00K estimate. The EPS represents a 70.93% improvement, and sales a 66.05% increase over the same period last year.

Portfolio Pulse from Benzinga Newsdesk

May 14, 2024 | 8:20 pm

Tenon Medical Inc has filed with the SEC for the resale of up to 5 million common shares by a selling stockholder. This move could potentially increase the supply of shares in the market.

Portfolio Pulse from Benzinga Newsdesk

May 10, 2024 | 8:40 pm

Benchmark analyst Bruce Jackson has maintained a Speculative Buy rating on Tenon Medical (NASDAQ:TNON) but has lowered the price target from $5 to $3.

Portfolio Pulse from Benzinga Newsdesk

April 15, 2024 | 3:14 pm

In Wednesday's pre-market session, several healthcare stocks showed significant movement. ARCA biopharma, Kintara Therapeutics, and Aesthetic Medical Intl were among the top gainers, with increases of 124.6%, 99.2%, and 53.03% respectively. On the losing side, SINTX Techs, Tenon Medical, and Acorda Therapeutics experienced declines of 21.0%, 16.42%, and 11.61%. The movements were attributed to various factors including recent earnings reports.

Portfolio Pulse from Benzinga Insights

April 03, 2024 | 12:09 pm

Tenon Medical, Inc. (NASDAQ:TNON) announced significant progress in a post-market study of its Catamaran SI Joint Fusion System for treating sacroiliac joint disorders. Preliminary results at 12-month follow-up show 100% fusion response, marked improvements in pain scores, disability, and high patient satisfaction. Study enrollment is expected to complete soon, with patients evaluated up to 24 months.

Portfolio Pulse from Benzinga Newsdesk

March 26, 2024 | 12:11 pm

Tenon Medical's stock price declined following the announcement of Q4 revenue results that fell short of expectations.

Portfolio Pulse from Benzinga Newsdesk

March 13, 2024 | 5:45 pm

Health care stocks experienced significant movements in Wednesday's intraday session, with notable gainers including Heron Therapeutics, TRACON Pharma, NuCana, Kintara Therapeutics, Cardiff Oncology, and Annexon, showing increases ranging from 26.36% to 35.4%. On the downside, Trxade Health, Tenon Medical, P3 Health Partners, Envoy Medical, Neumora Therapeutics, and Aesthetic Medical Intl saw declines between 16.28% and 22.6%. These movements were influenced by factors such as Q4 earnings reports.

Portfolio Pulse from Benzinga Insights

March 13, 2024 | 5:31 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.